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Introduction
Polychlorinated biphenyls (PCBs) are a group 
of structurally related organic compounds 
that, because of their inertness and ther-
mal stability, have been extensively used in 
various industrial and commercial applica-
tions. Although manufacturing of PCBs was 
banned in the late 1970s due to concerns 
of possible adverse effects in humans, these 
compounds still persist in the environment 
(Dyke et al. 2003). Similar concerns in the 
1970s also led to ban or severe restrictions on 
the use of the organochlorine pesticides hexa-
chlorobenzene (HCB) and dichlorodiphenyl-
trichloroethane (p,p´-DDT). Because of their 
lipophilic and persistent nature, p,p´-DDT 
and its metabolite dichlorodiphenyldichloro-
ethylene (p,p´-DDE), HCB, and PCBs accu-
mulate through the food chain, with seafood 
currently being the main route of human 
exposure (Halldorsson et al. 2007; Thompson 
and Boekelheide 2013). On entering the 
human body, these compounds dissolve in 
lipids but they can also bind to proteins in 
blood (Mohammed et al. 1990), and dur-
ing pregnancy they are readily transported 
across the placenta (Covaci et al. 2002; Park 
et al. 2008).
There is some evidence to suggest that 
prenatal exposure to PCBs may adversely 
affect development and maturation of the 
immune system (Lundqvist et al. 2006). 
Studies focusing on background prenatal 
exposures to PCBs have reported associations 
with increased respiratory and otitis media 
infections (Dallaire et al. 2006; Glynn et al. 
2008; Weisglas-Kuperus et al. 2000), altered 
immune cell counts (Glynn et al. 2008; Jusko 
et al. 2011; Weisglas-Kuperus et al. 2000), 
and reduced antibody responses to childhood 
vaccines (Heilmann et al. 2006; Weisglas-
Kuperus et al. 2000). Reports on atopic 
diseases such as asthma and wheeze have 
been divergent, with two studies reporting 
positive associations (Grandjean et al. 2010; 
Stolevik et al. 2011) and another reporting 
an inverse association (Weisglas-Kuperus 
et al. 2000, 2004). At least two studies have 
reported positive associations between pre-
natal exposures to p,p´-DDE and asthma in 
offspring at 4–9 years of age (Karmaus et al. 
2001; Sunyer et al. 2005), whereas evidence 
for immunological effects of HCB has mostly 
been obtained from animal studies (Ezendam 
et al. 2005; Michielsen et al. 1999).
Divergent findings on associations 
between prenatal exposures to these persis-
tent organochlorine pollutants (POPs) and 
asthma may relate to the fact that most stud-
ies have not had follow-up beyond 6–7 years 
of age, which would facilitate more accurate 
diagnoses of permanent asthma when cough-
ing and wheeze symptoms have stabilized. 
Divergent findings may also relate to differ-
ences in relative and absolute concentrations 
of different organochlorine compounds across 
studies due to temporal and regional differ-
ences (Longnecker et al. 2003). Furthermore, 
previous studies have mostly relied on self- 
or parental report to assess asthma, which 
may be prone to misclassification (Peat et al. 
1992, 2001).
The aim of this study was to investigate 
the association between maternal serum con-
centrations of PCBs, HCB, and p,p´-DDE 
in a cohort of environmentally exposed 
Danish pregnant women and risk of asthma in 
 offspring after 20 years of follow-up.
Methods
Study population. In Aarhus, Denmark, the 
Danish Fetal Origins 1988–1989 Cohort 
was formed and included 965 (80%) of 
1,212 eligible women with singleton preg-
nancies who attended a large prenatal clinic 
during the study period. The cohort has been 
described in detail elsewhere (Olsen et al. 
1995). Briefly, the data collection included a 
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Background: Previous findings suggest that developmental exposures to persistent organochlorine 
pollutants (POPs) may be detrimental for the development of the immune system in the offspring. 
Whether these suspected immunoregulatory effects persist beyond early childhood remains unclear.
oBjectives: The objective of this study was to evaluate the association between maternal serum 
concentrations of POPs and the risk of asthma in offspring after 20 years of follow-up.
Methods: A birth cohort with 965 women was formed in 1988–1989 in Aarhus, Denmark. 
Concentrations of six polychlorinated biphenyls (PCBs) (congeners 118, 138, 153, 156, 170, 180), 
hexachlorobenzene (HCB), and dichlorodiphenyldichloroethylene (p,p´-DDE) were quantified in 
maternal serum (n = 872) collected in gestation week 30. Information about offspring use of asthma 
medications was obtained from the Danish Registry of Medicinal Product Statistics.
results: Maternal serum concentrations of HCB and dioxin-like PCB-118 were positively 
associated with offspring asthma medication use after 20 years of follow-up (p for trend < 0.05). 
Compared with subjects in the first tertile of maternal concentration, those in the third tertile of 
PCB-118 had an adjusted hazard ratio (HR) of 1.90 (95% CI: 1.12, 3.23). For HCB the HR for 
the third versus the first tertile of maternal concentration was 1.92 (95% CI: 1.15, 3.21). Weak 
positive associations were also estimated for PCB-156 and the non-dioxin-like PCBs (PCBs 138, 
153, 170, 180). No associations were found for p,p´-DDE.
conclusions: Maternal concentrations of PCB-118 and HCB were associated with increased risk 
of asthma in offspring followed through 20 years of age.
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self-administered dietary questionnaire that 
was sent to the women 1 week before their 
scheduled 30th week antenatal visit. During 
the midwife visit the women participated in 
a face-to-face interview and gave information 
about diet, lifestyle, anthropometry, medical 
history, and socioeconomic status. A blood 
sample was collected and immediately sepa-
rated into erythrocytes, serum, and plasma, 
and was frozen at –20 °C. Information about 
the health of the mothers and birth outcomes 
was collected from the Danish Medical Birth 
Registry (Copenhagen, Denmark). 
Follow-up of children. In 2008 a follow-
up study was conducted including the off-
spring whose mothers were originally enrolled. 
Health information was obtained from the 
Danish population-based disease registries, 
and the offspring were also contacted and 
asked to complete a self- administered web-
based questionnaire covering anthropometry, 
lifestyle, diet, and health. The questionnaire 
included standardized questions on asthma 
from the International Study of Asthma 
and Allergies in Childhood (ISAAC) (Asher 
et al. 1995).
The study was approved by the Danish 
Data Protection Agency and the Danish 
Council of Ethics (Reference No. 20070157), 
and all participants gave written consent 
before inclusion in the study.
Exposure measures. A total of six PCBs 
(congeners 118, 138, 153, 156, 170, and 
180), p,p´-DDE, and HCB were measured 
in 200-μL aliquots from archived maternal 
serum using an extension of previously pub-
lished methods (Rantakokko et al. 2009) 
described in more detail elsewhere (Bjermo 
et al. 2013). In each batch of samples (n = 25), 
two blanks were included to control for pos-
sible laboratory contamination, in addition 
to two positive control samples. Average 
recoveries of measured POPs in the control 
samples were 97–106% of the certified val-
ues. The between-assay coefficient of varia-
tion was 4.0% (at 0.17 ng/mL) for PCB-118; 
2.7% (at 0.94 ng/mL) for PCB-153; 4.0% 
(at 0.08 ng/mL) for HCB; and 2.1% (at 
11.5 ng/mL) for p,p´-DDE. The limits of 
quantification (LOQs) for the PCBs and 
p,p´-DDE were 2–5 pg/mL. The LOQ for 
HCB was 25 pg/mL. The concentrations of 
the six PCB congeners, p,p´-DDE, and HCB 
were above the LOQs in all samples.
Outcome measures. Participants were 
classified as asthma cases using a previously 
validated definition based on medication data 
(Moth et al. 2007). We used Danish personal 
identification numbers to link each partici-
pant to the Registry of Medicinal Product 
Statistics (RMPS; Copenhagen, Denmark), 
which has collected information about all 
prescriptions redeemed in Danish pharma-
cies since 1995, and extracted information 
about all medications used to treat asthma 
[Anatomica l  Therapeut i c  Chemica l 
Classification System (ATC; World Health 
Organization, Oslo, Norway) codes R03A, 
R03B, R03C, and R03D]. 
Part ic ipants  who were prescribed 
medication(s) used for the treatment of asthma 
from 6 to 20 years of age were classified as 
cases, except for those who received prescrip-
tions for liquid β2-agonists only, or who 
received only one prescription for an inhaled 
β2-agonist or an inhaled steroid (Moth et al. 
2007). The date when an offspring became an 
asthma case for the first time was used in the 
analyses. As secondary outcome measures, we 
used three additional asthma definitions. Self-
reported lifetime doctor diagnosis of asthma 
was assessed from a standardized ISAAC ques-
tion on the follow-up questionnaire at 20 years 
of age and defined as offspring with a positive 
answer to this question. Offspring with a self-
reported doctor diag nosis were furthermore 
asked if they had used any asthma medica-
tions in the previous 12 months, to define self-
reported current use of asthma medications. 
We also used hospital diagnoses for asthma 
from the mandatory Danish National Patient 
Register (DNPR; Copenhagen, Denmark), 
which contains information about all hospi-
tal admissions in Denmark since 1977 and 
emergency department and outpatient con-
tacts since 1995. We defined a hospital asthma 
case as offspring with any asthma diagnosis 
(including hospital in-, out-, and emergency 
department patients) by the International 
Classification of Diseases, 10th Revision 
(ICD-10; National Board of Health, Denmark 
1994) codes J45.0, J45.1, J45.2, J45.8, J45.9 
J46.9, and 8th Revision (ICD-8; National 
Board of Health, Denmark 1977) codes 
493.00, 493.01, 493.02, 493.08, 493.09) from 
birth to 20 years of age. We used the date of 
the first hospital diagnosis in the analyses. 
Mother–child pairs available for  analysis. 
For the 965 women originally enrolled in 
the study, a sufficient amount of serum 
from week 30 of gestation was available for 
872 subjects (90%). These women and their 
offspring form the basis for this study. There 
were no major differences in baseline charac-
teristics between participants and nonpartici-
pants (n = 93) (data not shown). Information 
on use of medication (from 1995, offspring 
≈ 6 years of age) and hospital diagnosis (from 
birth) were available for all offspring. Self-
reported lifetime diagnosis of asthma and 
self-reported medication use in the preceding 
12 months were available for 654 offspring 
who filled out the web-based questionnaire at 
the 2008 follow-up.
Statistical analyses. We used the median 
and 10th and 90th percentiles to describe 
skewed variables, the mean ± SD for normal 
variables, and percentages for categorical 
variables. The dioxin-like PCBs (congeners 
118 and 156) and the non-dioxin-like PCBs 
(congeners 138, 153, 170, and 180) and the 
sum of all six congeners were analyzed sepa-
rately and aggregated on the bases of molar 
concentrations. Otherwise, wet-weight con-
centrations (nanograms per milliliter) were 
used for individual PCB congeners, HCB, and 
p,p´-DDE. In our primary analysis we exam-
ined the association between maternal PCB, 
HCB, and p,p´-DDE serum concentrations 
and offspring risk of asthma (based on asthma 
medication use) during 20 years of follow-up 
using Cox regression models. Maternal con-
centrations of the organochlorine compounds 
were divided into tertiles, and hazard ratios 
(HRs) and 95% CIs were calculated using age 
as the underlying time scale. Participants were 
thus considered at risk of asthma from their 
age at the start of follow-up in 1995, until 
time of becoming an asthma case (based on 
asthma use) or the defined end of follow-up 
(end of 2008), whichever came first. None of 
the participants were censored for other rea-
sons, such as death or emigration. Using this 
model we assumed that all offspring were free 
of asthma at the start of follow-up in 1995, 
when the offspring were around 6 years of age. 
Any prescription of asthma medication before 
1995 was assumed to be related to coughing 
and wheezing rather than asthma (Henderson 
et al. 2008). Visual inspection of cumulative 
residual plots did not indicate violations to 
the assumption of proportional hazards (data 
not shown). When examining associations 
between maternal concentrations of POPs and 
offspring asthma, we performed trend tests by 
assigning the median concentration to each 
exposure level (tertile) and included this in the 
regression models as a continuous variable.
To test the stability of our findings, both 
with respect to the asthma definition and 
the assumption that offspring were disease 
free until 6 years of age, we also estimated 
associations of PCB, HCB, and p,p´-DDE 
with first asthma diagnosis in the DNPR from 
birth to 20 years of age using Cox regres-
sion. Furthermore, we examined the relation 
between PCB, HCB, and p,p´-DDE, self-
reported lifetime diagnosis of asthma, and self-
reported current use of asthma medication 
using logistic regression.
Information on covariates was obtained 
from questionnaires completed by the moth-
ers during pregnancy and from maternal birth 
records, and the following covariates were 
included as adjustment factors in the multi-
variate models: maternal age (continuous), par-
ity (0, 1, ≥ 2), prepregnancy body mass index 
(BMI; kilograms per meter squared) (< 18.5, 
18.5 to < 25, 25 to < 30, ≥ 30), maternal 
education (elementary school, high school or 
technical school, university education, higher 
academic education, other education, or 
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missing), maternal smoking (nonsmokers, or 
< 5, > 5 to 15, > 15 cigarettes/day), maternal 
concentrations of cholesterol and triglycer-
ides (millimoles per liter), child’s birth weight 
(continuous), and child’s sex. We considered 
gestational age to be a potential intermediate 
variable and therefore excluded it from the 
model. Information on maternal smoking and 
education was missing for 6% of participants, 
and 3.5% had missing information on mater-
nal prepregnancy BMI. Complete informa-
tion was available for the remaining covariates. 
Missing covariate values were substituted using 
multiple imputation (PROC MI) in SAS. We 
did not adjust for fish intake to avoid overad-
justing our model (Halldorsson et al. 2008).
All tests were two-sided and statistical 
significance was considered at p < 0.05. All 
analyses were carried out using SAS statisti-
cal software (version 9.3; SAS Institute Inc., 
Cary, NC, USA).
Results
Characteristics of the study population are 
shown in Table 1. The median maternal 
serum concentration from gestational week 30 
was 1.37 ng/mL for PCB-153, 0.54 ng/mL 
for HCB, and 2.47 ng/mL for p,p´-DDE. 
Approximately 13% of the offspring had 
been prescribed asthma medications, whereas 
14% had a self-reported lifetime diagnosis of 
asthma. The proportion of offspring with a 
hospital asthma diagnosis was 4%, whereas 7% 
had self-reported use of asthma medication in 
the previous 12 months (Table 1).
Of those who reported ever being diag-
nosed with asthma by a doctor, 72% were 
also classified as cases based on the medica-
tion registry data; 76% of those classified as 
cases based on the medication registry data 
self-reported a diagnosis. Only 4% of those 
who were not classified as cases based on the 
medication registry data had a self-reported 
diagnosis, and only 3.5% of those who did 
not report a diagnosis were classified as cases 
based on the medication registry data. The 
agreement between the hospital diagnoses and 
the other outcomes was lower both for cases 
and noncases (20–31%) (data not shown).
Compared with mothers who had PCB 
concentrations in the first and second tertiles, 
mothers in the third tertile of PCB concen-
tration were older (30.4 years of age vs. 27.6 
and 29.1 in the first tertile and second ter-
tile, respectively), had higher mean fish intake 
(20.6 g/day vs. 18.8 and 18.4), higher alcohol 
intake (3.4 g/day vs. 2.5 and 2.9), were more 
likely to be nulliparous (64.6% vs. 52.4 and 
55.0), and had higher academic education 
(16.8% vs. 13.6 and 16.4) (Table 2). Similar 
associations were also observed across the ter-
tiles of HCB and p,p´-DDE exposures. There 
was no difference in maternal prepregnancy 
BMI across PCB tertiles. However, for HCB 
and p,p´-DDE maternal prepregnancy BMI 
was higher in the third tertiles compared with 
the first tertile (22.1 kg/m2 vs. 21.0 and 21.8 
vs. 20.9 for HCB and p,p´-DDE, respec-
tively). Offspring of mothers in the third ter-
tiles of PCB and HCB exposure had slightly 
shorter gestation (281 days) compared with 
offspring of mothers in the first (283 days) 
and second tertile (283 days). This difference 
was not observed across the p,p´-DDE tertiles. 
There was no difference in birth weight across 
any of the exposure tertiles. More boys than 
girls were born to mothers in the third tertile 
of PCB exposure (58.1% vs. 49.0% in the first 
tertile). For all four outcomes of asthma, there 
were higher numbers of asthma cases in the 
second and third tertiles of maternal PCB and 
HCB exposures compared to the first tertile.
HCB exposure in the third tertile was 
significantly associated with asthma clas-
sified according to medication use in both 
unadjusted (HR = 1.78; 95% CI: 1.12, 
2.84) and adjusted (HR = 1.92; 95% CI: 
1.15, 3.21) models (Table 3). We found that 
for the dioxin-like PCB-118 and PCB-156 
combined, HRs of asthma medication use 
increased across maternal tertiles of exposure. 
The association was strongest for maternal 
concentrations of PCB-118 with offspring 
asthma medication use after adjustment for 
covariates (third vs. first tertile 1.90; 95% CI: 
1.12–3.23). Although there were no sig-
nificant associations between maternal con-
centrations of the sum of all PCBs and the 
non-dioxin-like PCBs with asthma medication 
use, HRs were positive and increased with 
increasing tertiles of maternal exposure. There 
was no association between maternal concen-
trations of p,p´-DDE and offspring asthma 
medication. Overall, additional adjustment for 
gestational age did not alter any of the results 
(data not shown).
In most cases, maternal concentrations 
of PCBs and HCB were positively associated 
with asthma hospital diagnoses, self-reported 
lifetime diagnoses, and self-reported cur-
rent medication use (Table 4). The strongest 
associations were found between maternal 
concentrations and PCB-118 and HCB and 
self-reported current use of asthma medica-
tion. No association was observed between 
maternal concentrations of p,p´-DDE and 
any asthma outcomes.
The correlations between the compounds 
were high (Spearman r = 0.53–0.99), which 
made mutual adjustments problematic. 
However, when the analyses with PCB-118 
and HCB (Spearman r = 0.77) were mutu-
ally adjusted for each other in addition to 
the other covariates, we found weakened 
associations and wider CIs for PCB-118 
(HR = 1.47; 95% CI: 0.75, 2.86) and for 
HCB (HR = 1.58; 95% CI: 0.83, 3.01) with 
offspring asthma medication use comparing 
the third tertile to the first tertile of exposure 
(data not shown).
Discussion
In this study with 20 years of follow-up we 
observed positive associations between mater-
nal serum concentrations of PCBs and HCB 
and offspring use of asthma medications. For 
the PCBs, the strongest associations were 
found for the dioxin-like PCB-118. Similar 
associations were observed when we used 
three additional asthma outcomes, includ-
ing hospital diagnoses and self-reported 
Table 1. Maternal and offspring characteristics of 
872 mother–child pairs.
Characteristic
Median (10th, 
90th percentiles), 
mean ± SD, or 
n (%)
Maternal
Serum concentration (ng/mL)
PCB-118 0.17 (0.09, 0.30)
PCB-138 0.74 (0.41, 1.25)
PCB-153 1.37 (0.76, 2.26)
PCB-156 0.10 (0.06, 0.16)
PCB-170 0.37 (0.21, 0.59)
PCB-180 0.67 (0.38, 1.10)
Sum of PCBs (pmol/mL) 9.23 (5.32, 15.11)
HCB 0.54 (0.31, 0.87)
p,p´-DDE 2.47 (1.03, 5.66)
Maternal age at birth (years) 29.0 ± 4.2
Fish intake (g/day) 19.3 ± 15.6
Alcohol (g/day) 2.9 ± 3.8
Maternal cholesterol (mmol/L) 7.3 ± 1.3
Maternal triglycerides (mmol/L) 2.4 ± 0.8
Previous births
0 500 (57.3)
1 279 (32.0)
≥ 2 93 (10.7)
Cigarettes/day during pregnancy
0 493 (56.5)
> 0–5 99 (11.4)
> 5 to 15 188 (21.6)
> 15 41 (4.7)
Missing 51 (5.9)
Maternal education
Elementary school 103 (11.8)
High school or technical school 207 (23.7)
University 296 (33.9)
Higher academic 125 (14.3)
Other education 89 (10.2)
Missing 52 (6.0)
Prepregnancy BMI (kg/m2)
< 18.5 89 (10.2)
18.5 to < 25 676 (77.5)
25 to < 30 53 (6.1)
> 30 23 (2.6)
Missing 31 (3.6)
Offspring
Registry-based diagnoses (n = 872)
Asthma medication 111 (12.7)
Asthma hospitalization 32 (3.7)
Self-reported diagnoses (n = 654)
Lifetime doctor diagnosis 89 (13.6)
Current asthma medication use 48 (7.3)
Birth weight (g) 3493.7 ± 579.9
Gestational age (days) 282.3 ± 11.8
Boys 461 (52.9)
Age at follow-up (years) 19.6 ± 0.49
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diagnoses. No associations were found for 
maternal concentrations of p,p´-DDE and 
offspring asthma.
To our knowledge, only a few studies 
have examined developmental exposures to 
PCBs in relation to wheezing and asthma, 
and their results have varied, with some 
reporting positive associations (Grandjean 
et al. 2010; Stolevik et al. 2011), whereas 
another reported an inverse association 
(Weisglas-Kuperus et al. 2000, 2004). In 
contrast with these studies, we also estimated 
associations with specific PCB congeners, in 
addition to the sum of all quantified PCBs. 
Of the six quantified PCB congeners, only 
dioxin-like PCB-118 was significantly associ-
ated with offspring asthma, and a stronger 
association was observed for the two dioxin-
like congeners combined (PCBs 118 and 156) 
compared with the non-dioxin-like congeners 
(PCBs 138, 153, 170, and 180) and the sum 
of all PCBs.
The suspected influence of the dioxin-like 
PCBs on immunoregulation is, at least partly, 
thought to be related to interactions with 
the aryl hydrocarbon receptor (AhR). AhR-
mediated responses with dioxin and dioxin-
like compounds are thought to contribute to 
asthma pathogenesis through increased expres-
sion of inflammatory cytokines, including 
tumor necrosis factor-α and interleukin-1β, 
which in turn can induce mucin production, 
cell chemotaxis, and immunoglobulin E (IgE) 
production (Chiba et al. 2012). Whether 
AhR-mediated responses are relevant to effects 
of developmental exposures to dioxin-like 
Table 2. Maternal and offspring characteristics of 872 mother–child pairs across tertiles of maternal PCB, HCB, and p,p´-DDE serum concentrations.
Characteristic 1st tertile 2nd tertile 3rd tertile p-Valuea
PCB concentration (pmol/mL) (range) 1.4–7.7 7.7–11.1 11.1–80.6
Maternal
Maternal age at birth (years) 27.6 ± 4.1 29.1 ± 3.9 30.4 ± 4.2 < 0.001
Fish intake (g/day) 18.8 ± 16.3 18.4 ± 13.4 20.6 ± 16.7 0.21
Alcohol (g/day) 2.5 ± 3.7 2.9 ± 3.3 3.4 ± 4.2 0.01
Previous births (% nulliparous) 152 (52.4) 160 (55.0) 188 (64.6) 0.02
Smoking during pregnancy (% no) 157 (57.5) 182 (66.4) 154 (56.2) 0.09
Maternal education (% higher academic) 37 (13.6) 42 (15.4) 46 (16.8) 0.02
Prepregnancy BMI (kg/m2) 21.5 ± 3.0 21.5 ± 3.1 21.3 ± 3.2 0.72
Offspring
Birth weight (g) 3514.8 ± 507.7 3503.3 ± 563.8 3462.7 ± 541.1 0.47
Gestational age (days) 283 ± 10.8 283 ± 12.2 281 ± 12.3 0.03
Sex (% boys) 142 (49.0) 150 (51.6) 169 (58.1) 0.08
Asthma medication (n cases) 33 36 42 0.53
Asthma hospital diagnoses (n cases) 8 12 12 0.60
Self-reported diagnoses (n cases) 22 34 33 0.26
Current self-reported medication use (n cases) 11 18 19 0.35
HCB concentrations (ng/mL) (range) 0.1–0.5 0.5–0.6 0.6–2.5
Maternal
Maternal age at birth (years) 28.0 ± 4.1 28.9 ± 3.8 30.2 ± 4.2 < 0.001
Fish intake (g/day) 18.1 ± 14.5 19.5 ± 15.7 20.2 ± 16.3 0.24
Alcohol (g/day) 2.6 ± 3.8 3.0 ± 3.5 3.2 ± 3.9 0.14
Previous births (% nulliparous) 140 (48.3) 168 (57.7) 192 (66.0) < 0.001
Smoking during pregnancy (% no) 162 (59.6) 162 (59.3) 169 (61.2) 0.64
Maternal education (% higher academic) 36 (13.2) 44 (16.2) 45 (16.3) 0.22
Prepregnancy BMI (kg/m2) 21.0 ± 2.5 21.2 ± 2.4 22.1 ± 4.0 < 0.001
Offspring
Birth weight (g) 3483.2 ± 503.1 3534.7 ± 534.8 3463.0 ± 572.8 0.25
Gestational age (days) 283 ± 11.7 283 ± 10.9 281 ± 12.8 0.04
Sex (% boys) 147 (50.7) 155 (53.3) 159 (54.6) 0.63
Asthma medication (n cases) 28 35 48 0.04
Asthma hospital diagnoses (n cases) 8 12 12 0.60
Self-reported diagnoses (n cases) 20 34 35 0.07
Current self-reported medication use (n cases) 6 20 22 0.01
p,p´-DDE concentrations (ng/mL) (range) 0.2–1.9 1.9–3.2 3.3–38.8
Maternal
Maternal age at birth (years) 28.0 ± 4.2 28.8 ± 4.0 30.3 ± 4.1 < 0.001
Fish intake (g/day) 19.1 ± 14.7 17.7 ± 14.4 20.9 ± 17.3 0.05
Alcohol (g/day) 2.4 ± 3.2 3.1 ± 3.9 3.4 ± 4.1 0.01
Previous births (% nulliparous) 148 (51.0) 171 (58.8) 181 (62.2) 0.05
Smoking during pregnancy (% no) 162 (58.5) 174 (64.4) 157 (57.3) 0.59
Maternal education (% higher academic) 35 (12.6) 38 (14.1) 52 (19.0) 0.03
Prepregnancy BMI (kg/m2) 20.9 ± 2.7 21.5 ± 2.9 21.8 ± 3.6 0.003
Offspring
Birth weight (g) 3499.9 ± 533.5 3494.7 ± 519.8 3486.6 ± 561.1 0.96
Gestational age (days) 283 ± 11.7 282 ± 11.8 282 ± 12.0 0.49
Sex (% boys) 146 (50.3) 159 (54.6) 156 (53.6) 0.56
Asthma medication (n cases) 37 34 40 0.76
Asthma hospital diagnoses (n cases) 10 11 11 0.97
Self-reported diagnoses (n cases) 30 31 28 0.89
Current self-reported medication use (n cases) 16 16 16 0.99
Values are mean ± SD, n, or n (%).
aDifferences in maternal age, fish intake, alcohol, prepregnancy BMI, birth weight, gestational age across tertiles of maternal POP concentrations were evaluated using F-test. 
Differences in previous births, smoking, maternal education, sex, asthma medication, asthma hospital diagnoses, and self-reported diagnoses, self-reported medication across tertiles 
of maternal POP concentrations were evaluated using chi-square test.
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PCBs is unclear. Stronger associations of 
PCB-118 with asthma in our study are also 
indirectly supported by two studies. PCB-
118 was positively associated with cord IgE 
concentrations in a cross-sectional study of 
children from the Slovak Republic, but no 
associations were reported for the other quan-
tified PCB congeners (Reichrtova et al. 1999). 
In an in vitro study, treatment with PCB-118, 
but not PCB-153, led to a shift in the dif-
ferentiation of CD4+ T lymphocytes toward a 
T-helper 2–dominated response, which is con-
sistent with allergic disease (Gaspar-Ramirez 
et al. 2012).
We are not aware of previous studies spe-
cifically designed to examine developmen-
tal HCB exposures and the risk of offspring 
asthma. HCB was not associated with wheez-
ing or asthma in a cross-sectional study of 
124 Japanese adults (Miyake et al. 2011), but 
HCB has been found to induce airway hyper-
reactivity in tissue from HCB-exposed Brown 
Norway rats (Michielsen C et al. 2002; 
Michielsen CP et al. 2001). HCB has also 
been reported to show some agonist activity 
with the AhR (van Birgelen 1998), which 
suggests that HCB might affect the immune 
system and asthma through AhR-mediated 
mechanisms.
In contrast to two previous studies 
(Karmaus et al. 2001; Sunyer et al. 2005), we 
did not find any associations between mater-
nal concentrations of p,p´-DDE and offspring 
asthma. It is worth noting that the children in 
the previous studies were younger (4–9 years 
of age) than our study population, and their 
findings may therefore at least partly reflect 
associations with wheezing symptoms that 
often resolve later in childhood (Bel 2004; 
Henderson et al. 2008; Taussig et al. 2003).
Breastfeeding may play an important role 
on the development of the infant’s immune 
system (Belderbos et al. 2012). On the other 
hand, breastfeeding is also a major source 
of exposure to PCBs and other lipophilic 
pollutants during the first year of life, with 
accumulation that is proportional to mater-
nal concentrations (Wang et al. 2004) and 
the duration of breastfeeding (Patandin et al. 
1997). In a study of prenatal and lactational 
exposures to PCBs in a relatively highly 
exposed fishing community (Grandjean et al. 
2010), duration of breastfeeding was strongly 
correlated with offspring IgE concentra-
tions at 7 years of age, whereas only a non-
significant positive association was observed 
for prenatal PCB exposures. Although the 
focus of that study was on allergic sensiti-
zation and not asthma, the results support 
the potential importance of lactational POP 
exposures to immunoregulation. Absence of 
information on breastfeeding in our study 
is therefore a major limitation. As a result, 
we therefore cannot determine to which 
degree the associations observed in our 
study may be related to in utero exposure, 
lactational exposures, or a combination of 
both. Although speculative, previous sur-
veys suggest that most children in Denmark 
were exclusively breastfed during the study’s 
time period (Vestergaard et al. 1999), which 
may possibly reduce potential confounding 
by breastfeeding.
The long prospective follow-up period 
and the high inclusion of 90% (872/965) of 
the offspring of women originally enrolled in 
the cohort are major strengths of our study. 
In contrast to previous studies that have 
mostly relied on self-reported asthma, our 
outcome measure was based on objective reg-
ister data, where misclassification of ICD-10 
asthma diagnoses has been shown to be low 
(Østergaard Jensen et al. 2010). A possible 
limitation of the definition of asthma based 
on medication data is that medicine may have 
been prescribed to clarify a diagnosis, and 
this method may therefore overestimate the 
true prevalence of disease; however, we used 
a definition based on medication data that 
has been validated against medical records 
with a sensitivity of 63% and specificity of 
86% compared with a doctor diagnosis of 
asthma (Moth et al. 2007). Furthermore, we 
did not consider prescriptions before 6 years 
of age, which we believe is a strength because 
many children are prescribed asthma medica-
tions in the first years of life, although they 
do not necessarily develop clinical asthma 
(Ingvardsen et al. 2000). In most analyses 
with PCBs and HCB, we observed positive 
associations with the outcomes. The analyses 
based on the hospital diagnoses and the self-
reported diagnoses of asthma did not always 
reach statistical significance, possibly due to 
a small number of cases and fewer subjects 
in the analyses, respectively. The significant 
associations observed between PCB-118 and 
HCB and self-reported current use of asthma 
medication may suggest that the associations 
are driven by persistent cases of asthma that 
require continuous medical  treatment at 
20 years of age.
Table 3. Associations between maternal PCBs, HCB, and p,p´-DDE serum concentrations and offspring 
asthma medication use after 20 years of follow-up (n = 872) [HRa (95% CI)].
POPs in tertiles (range) Raw model Adjusted modelb 
PCB–118 (ng/mL)
1st (0.02–0.14) 1.00 1.00
2nd (> 0.14–0.20) 1.50 (0.92, 2.45) 1.60 (0.96, 2.66)
3rd (> 0.20–0.61) 1.69 (1.05, 2.73) 1.90 (1.12, 3.23)
p for trendc 0.04 0.02
PCB–156 (ng/mL)
1st (0.01–0.08) 1.00 1.00
2nd (> 0.08–0.12) 1.33 (0.82, 2.15) 1.38 (0.84, 2.26)
3rd (> 0.12–0.92) 1.43 (0.90, 2.29) 1.45 (0.85, 2.46)
p for trendc 0.15 0.20
Dioxin-like PCBs (pmol/mL)d
1st (0.13–0.67) 1.00 1.00
2nd (> 0.67–0.96) 1.45 (0.90, 2.35) 1.56 (0.95, 2.56)
3rd (> 0.96–4.10) 1.59 (0.99, 2.55) 1.75 (1.02, 2.98)
p for trendc 0.07 0.05
Non-dioxin-like PCBs (pmol/mL)e
1st (1.23–7.09) 1.00 1.00
2nd (> 7.10–10.12) 1.10 (0.69, 1.77) 1.15 (0.70, 1.86)
3rd (> 10.12–76.55) 1.30 (0.83, 2.06) 1.30 (0.78, 2.17)
p for trendc 0.24 0.32
Sum of all PCBs (pmol/mL)f
1st (1.43–7.72) 1.00 1.00
2nd (> 7.73–11.11) 1.10 (0.68, 1.76) 1.15 (0.70, 1.87)
3rd (> 11.11–80.65) 1.30 (0.83, 2.06) 1.30 (0.78, 2.17)
p for trendc 0.24 0.32
HCB (ng/mL)
1st (0.07–0.45) 1.00 1.00
2nd (> 0.45–0.63) 1.26 (0.77, 2.07) 1.31 (0.79, 2.17)
3rd (> 0.63–2.45) 1.78 (1.12, 2.84) 1.92 (1.15, 3.21)
p for trendc 0.01 0.01
p,p´–DDE (ng/mL)
1st (0.20–1.86) 1.00 1.00
2nd (> 1.86–3.24) 0.91 (0.57, 1.44) 0.92 (0.5, 1.47)
3rd (> 3.25–38.77) 1.09 (0.70, 1.71) 1.09 (0.67, 1.77)
p for trendc 0.62 0.64
aEstimated in a Cox regression model with age as the underlying time scale.  bAdjusted for maternal age, prepregnancy 
BMI, parity, maternal smoking, maternal education, maternal alcohol intake, maternal cholesterol, maternal triglycer-
ides, child birth weight, and sex. cEstimated with median concentrations in each tertile entered in the Cox regression 
model as a continuous variable. dSum of PCB congeners 118 and 156. eSum of PCB congeners 138, 153, 170, and 180. 
fSum of PCB congeners 118, 138, 153, 156, 170, 180.
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As in any other observational study, 
we cannot exclude the possibility that the 
observed associations were influenced by 
residual or unmeasured confounding, includ-
ing breastfeeding. The POPs included in 
our study were highly correlated, and con-
sequently we could not distinguish the con-
tributions of individual compounds to the 
observed associations. The potential con-
founders that we included as adjustment 
factors in our regression models seemed to 
influence our results to a minimal degree, sug-
gesting limited residual confounding.
In conclusion, this study provides epide-
miologic evidence that maternal concentra-
tions of dioxin-like PCBs and HCB may be 
associated with the offspring’s risk of devel-
oping asthma that persists into adulthood. 
However, we cannot exclude the possibil-
ity that these associations may be mediated 
through postnatal exposures to POPs. Our 
results provide support for the hypothesis 
that early-life exposure to POPs may have 
immunoregulatory effects. Although the con-
centrations of these particular environmental 
contaminants have generally decreased since 
the late 1980s, industrial reduction in pro-
duction and usage of one particular class of 
contaminants has typically been matched 
with a corresponding rise in the production 
and usage of other related industrial chemicals 
(Fangstrom et al. 2008; Haug et al. 2009) 
that have been less extensively studied with 
respect to potential health effects. In addi-
tion, evidence regarding the potential health 
effects of POPs will continue to be relevant 
to populations with high risks of occupational 
exposures (Schettgen et al. 2012) and to com-
munities with high consumption of fish and 
other marine species (Birgisdottir et al. 2012).
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